ZAS Corporation Launches Revolutionary Antibiotic Polymyxin B to Combat Multidrug-Resistant Infections in Bangladesh
ZAS Corporation is proud to announce the successful launch of Polymyxin B, a groundbreaking antibiotic from our Critical Care division. […]
